新生児の免疫不全スクリーニングによる結核ワクチン接種の安全性の向上
Gregor Nosan1, Andreja Cerkvenik Škafar2
1Department of Neonatology, Division of Paediatrics, University Medical Centre Ljubljana, Bohoričeva ulica 20, 1000 Ljubljana, Slovenia; Department of Paediatrics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
Vaccine
|September 4, 2025
まとめ
スロベニアでは,バチルス・カルメッテ・ゲーリン (BCG) ワクチンを投与する前に,新生児の免疫不全を検診し,結核 (TB) の予防の安全性を高めています. この精密なアプローチは 脆弱な乳児を保護しながら 早期の結核予防を保証します
科学分野:
- 免疫学 と 感染症
- ワクチン学
- 公衆衛生政策
背景:
- 結核 (TB) は依然として世界的な健康問題であり,毎年何百万人もの新規症例が発生し,多剤耐性菌株による課題となっています.
- 乳児の重度の結核予防にはバチルス・カルメッテ・ゲーリン (BCG) ワクチン接種が不可欠ですが,免疫低下の新生児にはリスクがあります.
- 免疫の先天的誤差 (IEI) のスクリーニングは,BCGワクチン接種前に,脆弱な乳児の拡散感染リスクを軽減するために不可欠です.
研究 の 目的:
- 新生児の先天性免疫障害 (IEI) のスクリーニングと新生児のバチルス・カルメッテ・ゲリン (BCG) ワクチン接種を統合するスロベニアの革新的なアプローチについて説明する.
- 精密ワクチン接種戦略を強調し,低発症環境で,早期の結核予防と乳児の安全をバランスとすること.
- 結核予防プロトコルの近代化を目指す他の低罹患国にとってのモデルを提示する.
主な方法:
- 免疫の先天性欠陥 (IEI) に対する新生児の普遍的なスクリーニングを2024年から実施する.
- 新生児のBCGワクチン接種プロトコルを2025年に改定し,ワクチン接種前にIEIスクリーニング結果を義務付ける.
- 血液採取の特定のタイミング (≥48時間),結果の可用性 (5~7日),BCG投与 (7~14日).
主要な成果:
- 新生児の予防接種プロトコルを改定し,BCG投与前に免疫低下の新生児を特定することで,乳児の安全を優先する.
- BCGワクチン接種戦略にリアルタイムの免疫遺伝データを成功裏に統合する
- 低発生国における精密ワクチン接種の実現可能なモデルを実証する.
結論:
- スロベニアの統合されたIEIスクリーニングとBCGワクチン接種プロトコルは,新生児結核の予防に安全で効果的なアプローチを提供します.
- この精密ワクチン接種戦略は 結核の予防と 脆弱な集団の保護に向けた 世界的な取り組みと一致しています
- スロベニアのモデルは,ワクチン接種プログラムを最適化することを目指す他の低発生国にとって貴重な枠組みを提供します.
さらに関連する動画
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.7K
08:10A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
13.9K
関連する概念動画
01:26Pulmonary Tuberculosis IV
196
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
196
01:28Pulmonary Tuberculosis V
236
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
236
01:29Pulmonary Tuberculosis I
321
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
321
01:28Pulmonary Tuberculosis II
339
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
339
01:31Pulmonary Tuberculosis III
438
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
438
01:25Immunodeficiency Diseases
1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.2K